AVEO Pharmaceuticals, Inc.

AVEO Reports Third Quarter 2010 Financial Results and Recent Developments

AVEO Reports Third Quarter 2010 Financial Results and Recent Developments

November 4, 2010

Current Financial Position Supports Expanding and Accelerating Clinical Development Plans for Tivozanib

[Note: To view this press release in it's entirety, including the Third Quarter Results in detail, click here.]

Helicos BioSciences Corporation

Helicos BioSciences Amends Patent Infringement Lawsuit Against Pacific Biosciences to Include Illumina and Life Technologies

Helicos BioSciences Amends Patent Infringement Lawsuit Against Pacific Biosciences to Include Illumina and Life Technologies

October 25, 2010

CAMBRIDGE, Mass., Oct 25, 2010 (BUSINESS WIRE) -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that it has amended its lawsuit against Pacific Biosciences of California, Inc. for patent infringement by naming Illumina, Inc. and Life Technologies Corporation as additional defendants. The amended lawsuit, Helicos BioSciences Corporation v. Pacific Biosciences of California, Inc., Life Technologies Corporation, and Illumina, Inc., No.

Joule Unlimited, Inc.

U.S. Senator John Kerry Visits Joule, Calls Renewable Fuel Platform "Game Changing"

U.S. Senator John Kerry Visits Joule, Calls Renewable Fuel Platform "Game Changing"

October 14, 2010

Cambridge, Mass. – October 14, 2010 – U.S. Senator John Kerry today visited the office and laboratories of Joule Unlimited, Inc., calling its technology platform potentially "game changing" in the all-important race to replace fossil fuels. The Senator met with members of Joule's executive team and toured the site for a first-hand look at Joule's advances in biology and integrated system design, which together form a platform for renewable fuel production that will eclipse the scale, efficiencies and net energy yield of any known alternative to fossil fuels today.

Black Duck Software, Inc.

Black Duck Software Acquires Ohloh.net from Geeknet; Purchase a Boon to Developers

Black Duck Software Acquires Ohloh.net from Geeknet; Purchase a Boon to Developers

October 5, 2010

Will Integrate Ohloh's FOSS Software Directory and Community with its Koders.com Site to Promote Expanded Open Source Adoption

WALTHAM, Mass., Oct. 5 /PRNewswire/ -- Black Duck Software, the leading global provider of products and services for accelerating software development through the managed use of open source software, today announced that it has acquired Ohloh.net from Geeknet, Inc. (Nasdaq: GKNT). The transaction closed on September 30, 2010.

Oasys Water, Inc.
LS9
Ze-gen, Inc.

Three Flagship Portfolio Companies, LS9, Ze-gen and Oasys, Named AlwaysOn 2010 GoingGreen Silicon Valley 100 Winners

Three Flagship Portfolio Companies, LS9, Ze-gen and Oasys, Named AlwaysOn 2010 GoingGreen Silicon Valley 100 Winners

October 5, 2010

Full text of the announcement aricle on AlwaysOn.com is included below, with the list of all companies being honored.



Announcing the 2010 GoingGreen Silicon Valley 100

Posted by: Weston McBride on October 5, 2010

Smart money and clever business innovations push the green community to create new solutions for tomorrow's clean world.

Flagship’s Jim Matheson and David Barry named to Biofuels Digest’s list of “The Top 100 People in Bioenergy.” Also listed are three Flagship portfolio company CEOs: Bill Sims of Joule Unlimited, Bill Haywood of LS9 and Bill Brady of Mascoma.

Flagship’s Jim Matheson and David Barry named to Biofuels Digest’s list of “The Top 100 People in Bioenergy.” Also listed are three Flagship portfolio company CEOs: Bill Sims of Joule Unlimited, Bill Haywood of LS9 and Bill Brady of Mascoma.

October 11, 2010

An excerpt from the announcement is below. Read the full original posting here, with a link to the entire Top 100 list.
 

AVEO Pharmaceuticals, Inc.

AVEO Pharmaceuticals Regains Worldwide Rights to Develop and Commercialize Anti-HGF Antibody Candidate AV-299

AVEO Pharmaceuticals Regains Worldwide Rights to Develop and Commercialize Anti-HGF Antibody Candidate AV-299

September 30, 2010

CAMBRIDGE, Mass., September 30, 2010 - AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO), a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that AVEO has regained worldwide rights from Merck (through its subsidiary, Schering Corporation) to develop and commercialize AV-299 (also known as SCH 900105), its anti-hepatocyte growth factor (HGF) antibody candidate. 

Advanced Electron Beams, Inc

Advanced Electron Beams Names Richard M. Feldt as Chief Executive Officer

Advanced Electron Beams Names Richard M. Feldt as Chief Executive Officer

September 28, 2010
Richard M. Feldt, highly experienced & respected clean technology executive, joins Advanced Electron Beams to lead company through next phase of growth.
 
CGI Pharmaceuticals, Inc.

Cellular Genomics Signs Kinase Research and Development Collaboration Agreement with Schering AG

Cellular Genomics Signs Kinase Research and Development Collaboration Agreement with Schering AG

December 12, 2002

BRANFORD, Conn., Dec. 12 /PRNewswire/ -- Cellular Genomics Inc. (CGI) today announced that it has entered into a collaborative research agreement with Schering AG (SHR), in which CGI will apply its proprietary chemical genetics technologies to the study of an undisclosed target kinase selected by Schering. Under the terms of the agreement, CGI will receive an undisclosed upfront fee and a series of milestone payments over a period of 15 months.

Renovis

Renovis, Inc. Announces Acquistion of Assets from Centaur Pharmaceutials Inc.

Renovis, Inc. Announces Acquistion of Assets from Centaur Pharmaceutials Inc.

December 12, 2002

Acquisition Accelerates Company's Drug Discovery and Clinical Development Programs